Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
about
Intracellular Delivery of Molecular Cargo Using Cell-Penetrating Peptides and the Combination StrategiesThe potential of polymeric micelles in the context of glioblastoma therapy.Interaction between cell-penetrating peptides and acid-sensitive anionic oligopeptides as a model for the design of targeted drug carriers.A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option.Brain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles.Self-assembled penetratin-deferasirox micelles as potential carriers for hydrophobic drug delivery.Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency.Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.Nanowired drug delivery for neuroprotection in central nervous system injuries: modulation by environmental temperature, intoxication of nanoparticles, and comorbidity factors.Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics.Cell-penetrating Peptide-mediated therapeutic molecule delivery into the central nervous system.Application of nanomedicine for crossing the blood-brain barrier: Theranostic opportunities in multiple sclerosis.Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.Intranasal brain-targeted clonazepam polymeric micelles for immediate control of status epilepticus: in vitro optimization, ex vivo determination of cytotoxicity, in vivo biodistribution and pharmacodynamics studies.Empowering the Potential of Cell-Penetrating Peptides for Targeted Intracellular Delivery via Molecular Self-Assembly.Gelatin nanoparticles enhance the neuroprotective effects of intranasally administered osteopontin in rat ischemic stroke model.Intranasal administration of antiretroviral-loaded micelles for anatomical targeting to the brain in HIV.Contribution of both olfactory and systemic pathways for brain targeting of nimodipine-loaded lipo-pluronics micelles: in vitro characterization and in vivo biodistribution study after intranasal and intravenous delivery.Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles.Cell-penetrating peptides induce apoptosis and necrosis through specific mechanism and cause impairment of Na+-K+-ATPase and mitochondria.Different oligoarginine modifications alter endocytic pathways and subcellular trafficking of polymeric nanoparticles.Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting.
P2860
Q26795943-FB1DD195-F263-4661-90E9-14C2D6931E5DQ27693205-2BA1651C-2C17-4332-B3D7-FF6DB52068EEQ33577349-6ACBEB7F-8556-479E-9EAA-8B018D426AB6Q34396290-3D736B57-6A32-4422-A7C6-58FB105A0BE3Q34961530-88C91316-B51D-4073-8D59-39636F3F9A6FQ35631409-BB9F0567-5E7C-44C4-B5E1-CFEC96EA5CA3Q36003406-61B819BD-C460-4F3B-B9A6-C23AF5C14682Q36612939-691A8EEC-B347-4B39-A733-3A6929FD8A2EQ37967666-B4017272-7108-4CD7-8153-DA51A07385F6Q38120721-E4BB95EF-C783-4D80-922A-D175E27A6526Q38133554-9DFA7F6D-603C-46DB-A387-9A74DD423F74Q38896543-1098E8C6-3B86-4A26-9F78-0314904ED3F3Q41829353-0868EEF5-7D82-4F35-96C6-EE6CC1F9A535Q46181062-82961779-7C6C-4170-9B2E-2F8B9A4E5037Q47400885-5CAF0338-B2A0-4367-AF6F-ABEF816946E9Q48273978-0ADDBD61-C5CC-4CF6-A6A4-2DA6D8865710Q48284053-1D70FB4C-F52D-435F-BF50-1FF80360BB79Q48326356-9D18595D-16E2-4ADD-8049-542D6807B013Q48384614-3CE689E8-918F-4AE9-B163-770223FB88D6Q50759545-A264B4D5-80D7-4D72-94A5-9AC9E6F29D4FQ51196223-0405FA83-3972-4912-90E4-F57DB35B3307Q52654049-47AC79B0-F81A-4F90-A4F0-FAF681BFB718
P2860
Cell-penetrating peptide-modified block copolymer micelles promote direct brain delivery via intranasal administration.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cell-penetrating peptide-modif ...... via intranasal administration.
@en
Cell-penetrating peptide-modif ...... via intranasal administration.
@nl
type
label
Cell-penetrating peptide-modif ...... via intranasal administration.
@en
Cell-penetrating peptide-modif ...... via intranasal administration.
@nl
prefLabel
Cell-penetrating peptide-modif ...... via intranasal administration.
@en
Cell-penetrating peptide-modif ...... via intranasal administration.
@nl
P2093
P2860
P1476
Cell-penetrating peptide-modif ...... via intranasal administration
@en
P2093
Hiroaki Okada
Hiroyuki Taki
Yuuki Takashima
P2860
P304
P356
10.1007/S11095-011-0440-7
P577
2011-04-16T00:00:00Z